A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency is a research paper published in Journal of Child Neurology (2021). On theSindex it has a DataRank of 0.588. It has been cited 17 times, with 11 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.434
From this paper's citation signal
Citation Network Contribution
0.154
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 11 citers.
NINDS NIH HHS
Grant: R01 NS082286
NICHD NIH HHS
Grant: P50 HD105351
National Institutes of Health
Grant: 5R01NS082286-03
Phase II Trial of SGS-742 in Succinic Semialdehyde Dehydrogenase Deficiency
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals